FOLH1 and neoplasm: Biodistribution as well as PET imaging studies of the three 64Cu-labeled antibodies showed specific tumor uptake in PSMA-positive C4-2 tumors, whereas the uptake of tracers in PSMA-negative DU 145 tumors was found to be at the background level.